Literature DB >> 12112673

Assessing equilibration and convergence in biomolecular simulations.

Lorna J Smith1, Xavier Daura, Wilfred F van Gunsteren.   

Abstract

If molecular dynamics simulations are used to characterize the folding of peptides or proteins, a wide range of conformational states needs to be sampled. This study reports an analysis of peptide simulations to identify the best methods for assessing equilibration and sampling in these systems where there is significant conformational disorder. Four trajectories of a beta peptide in methanol and four trajectories of an alpha peptide in water, each of 5 ns in length, have been studied. Comparisons have also been made with two 50-ns trajectories of the beta peptide in methanol. The convergence rates of quantities that probe both the extent of conformational sampling and the local dynamical properties have been characterized. These include the numbers of hydrogen bonds populated, clusters identified, and main chain torsion angle transitions in the trajectories. The relative equilibrium rates of different quantities are found to vary significantly between the two systems studied reflecting both the differences in peptide primary structure and the different solvents used. A cluster analysis of the simulation trajectories is identified as a very effective method for judging the convergence of the simulations. This is particularly the case if the analysis includes a comparison of multiple trajectories calculated for the same system from different starting structures. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12112673     DOI: 10.1002/prot.10144

Source DB:  PubMed          Journal:  Proteins        ISSN: 0887-3585


  35 in total

1.  Quantifying uncertainty and sampling quality in biomolecular simulations.

Authors:  Alan Grossfield; Daniel M Zuckerman
Journal:  Annu Rep Comput Chem       Date:  2009-01-01

2.  Comparison of multiple molecular dynamics trajectories calculated for the drug-resistant HIV-1 integrase T66I/M154I catalytic domain.

Authors:  Alessandro Brigo; Keun Woo Lee; Gabriela Iurcu Mustata; James M Briggs
Journal:  Biophys J       Date:  2005-03-11       Impact factor: 4.033

3.  Force field impact and spin-probe modeling in molecular dynamics simulations of spin-labeled T4 lysozyme.

Authors:  Ileana Stoica
Journal:  J Mol Model       Date:  2005-04-02       Impact factor: 1.810

4.  Ensemble versus single-molecule protein unfolding.

Authors:  Ryan Day; Valerie Daggett
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-09       Impact factor: 11.205

5.  The unfolded state of the villin headpiece helical subdomain: computational studies of the role of locally stabilized structure.

Authors:  Lauren Wickstrom; Asim Okur; Kun Song; Viktor Hornak; Daniel P Raleigh; Carlos L Simmerling
Journal:  J Mol Biol       Date:  2006-05-15       Impact factor: 5.469

6.  Ensemble-based convergence analysis of biomolecular trajectories.

Authors:  Edward Lyman; Daniel M Zuckerman
Journal:  Biophys J       Date:  2006-04-14       Impact factor: 4.033

7.  On the structural convergence of biomolecular simulations by determination of the effective sample size.

Authors:  Edward Lyman; Daniel M Zuckerman
Journal:  J Phys Chem B       Date:  2007-10-13       Impact factor: 2.991

8.  Statistical prediction and molecular dynamics simulation.

Authors:  Ben Cooke; Scott C Schmidler
Journal:  Biophys J       Date:  2008-08-01       Impact factor: 4.033

9.  Is an intuitive convergence definition of molecular dynamics simulations solely based on the root mean square deviation possible?

Authors:  B Knapp; S Frantal; M Cibena; W Schreiner; P Bauer
Journal:  J Comput Biol       Date:  2011-06-24       Impact factor: 1.479

10.  Entropy calculation of HIV-1 Env gp120, its receptor CD4, and their complex: an analysis of configurational entropy changes upon complexation.

Authors:  Shang-Te D Hsu; Christine Peter; Wilfred F van Gunsteren; Alexandre M J J Bonvin
Journal:  Biophys J       Date:  2004-10-15       Impact factor: 4.033

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.